Cindy Pan

Cindy Pan focuses her practice on initial public offerings and other capital markets transactions on the Hong Kong Stock Exchange, listing rules and securities regulations compliance and other general corporate matters.
Cindy is a native Mandarin speaker and is fluent in English.

Representative Matters:
Equity Offering

• ImmuneOnco, a clinical-stage biotech company, on its HK$319 million IPO and listing on HKEX 
• The sole sponsor CICC and other underwriters on HK$791 million (US$101 million) IPO and listing of Laekna, a leading biotechnology company, on HKEX.
• STAR CM, a variety program intellectual property creator and operator, on its HK$390 million IPO and listing on HKEX.
• GOGOX, an online intracity logistics platform, on its HK$670.8 million IPO and listing on HKEX.
• Asymchem, a leading contract development manufacturing organization (CDMO) serving the global pharmaceutical industry, on its US$979 million IPO and listing on HKEX. This is the largest healthcare HK IPO in 2021.
• Country Style Cooking Restaurant Chain, a leading catering group, on its proposed IPO on HKEX (on-going)
• Goldman Sachs and CICC as joint sponsors on the proposed IPO of Insight Lifetech Co., Ltd., a leading medical devices company, on HKEX (on-going)
• WZ Group Limited, a leading supply chain service provider in the pan-building material industry, on its proposed IPO on HKEX (on-going)

Listed Issuer’s Compliance

• ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKEX: 1541) on its post-listing compliance matters
• GOGOX HOLDINGS LIMITED (HKEX: 2246) on its post-listing compliance matters
• Hilong Holding Limited (HKEX: 1623) on its post-listing compliance matters